Current Roles

Employees:
127
Revenue:
$6.8M
About
Founded in 2015 by a team responsible for the FDA's approval of the world's first cancer immunotherapy and experts in the field of recombinant protein based immunotherapies, Alpine Immune Sciences was created to capitalize on our unique understanding of immunology, modifying the complexities of the immune synapse for the benefit of patients living with cancer, autoimmune disorders, and other diseases. Traded on NASDAQ under ticker ALPN.
Alpine Immune Sciences Address
188 East Blaine Street
Seattle, WA
United States
Alpine Immune Sciences Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.